Number needed to treat and harm for lecanemab and donanemab in early Alzheimer disease.

Authors

Marco Spallazzi, Alessandro Zilioli, Livia Ruffini, Bruno Pietro Imbimbo

Published in

Journal of neurology. Volume 273. Issue 7. Jul 01, 2026. Epub Jul 01, 2026.

PMID:
42384109
Bibliographic data and abstract were imported from PubMed on 01 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.